Fig. 6

Runx1 overexpression in chondrocytes promoted Yap expression in vitro, and local Runx1 overexpression by AAV protected against OA in an ACLT mouse model in vivo. a Images under a fluorescence microscope. pMXs-GFP (GFP) and Runx1 overexpression (Runx1-OE) by pMXs-3xFlag-Runx1 retrovirus transfection in ATDC5 cells that were induced to chondrocytes for 14 days. Bar: 100 μm. b Alcian blue staining in ATDC5 cells that were induced to differentiate into chondrocytes for 14 days. Bar: 100 μm. c Western blot of induced cells. d Schematic display of ACLT surgery-induced OA and subsequent AAV-Runx1/AAV-YFP treatment workflow. e Images under a fluorescence microscope for YFP expression in treated mouse knee joints. Bar: 50 μm. f Radiography results showed that AAV-Runx1 prevented ACLT-mediated OA. The arrow shows osteophytes and worn articular cartilage. g Knee joint safranin O (SO) staining of AAV-treated ACLT-mediated osteoarthritic knees. The blue line shows the space of the knee joint. Bar: 50 μm. h OARSI score of (g). The results are presented as the mean ± SD, n = 3, *P < 0.05, **P < 0.01, ***P < 0.001